Evidence map›Paper›PMID 32991337›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

Improved Viral Suppression With Streamlined Care in the SEARCH Study.

Matthew D Hickey, James Ayieko, Dalsone Kwarisiima, Fredrick J Opel, Asiphas Owaraganise, Laura B Balzer, Gabriel Chamie, Vivek Jain, James Peng, Carol Camlin and 6 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01864603 (Sustainable East Africa Research in Community Health), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Matthew D HickeyDivision of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
James AyiekoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Dalsone KwarisiimaInfectious Disease Research Collaboration, Kampala, Uganda.
Fredrick J OpelCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Asiphas OwaraganiseInfectious Disease Research Collaboration, Kampala, Uganda.
Laura B BalzerSchool of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA.
Gabriel ChamieDivision of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
Vivek JainDivision of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
James PengDivision of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
Carol CamlinDepartment of Medicine, Center for AIDS Prevention Studies, UCSF, San Francisco, CA.
Edwin D CharleboisDepartment of Medicine, Center for AIDS Prevention Studies, UCSF, San Francisco, CA.
Craig R CohenDepartment of Obstetrics, Gynecology and Reproductive Sciences, UCSF, San Francisco, CA.
Elizabeth A BukusiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Moses R KamyaInfectious Disease Research Collaboration, Kampala, Uganda.
Maya L PetersenDivision of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA.
Diane V HavlirDivision of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
Kenya Medical Research Institute · KEInfectious Diseases Research Collaboration · UGSan Francisco AIDS Foundation · USMakerere University · UGUniversity of California, Berkeley · USUniversity of Massachusetts Amherst · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
NIAID NIH HHS R01 AI074345NIAID NIH HHS T32 AI060530NIAID NIH HHS U01 AI099959NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069496PEPFAR
6 · The paper itself

Abstract

backgroundHIV differentiated service delivery (DSD) models are scaling up in resource-limited settings for stable patients; less is known about DSD outcomes for patients with viremia. We evaluated the effect on viral suppression (VS) of a streamlined care DSD model implemented in the SEARCH randomized universal test and treat trial in rural Uganda and Kenya (NCT:01864603).

methodsWe included HIV-infected adults at baseline (2013) who were country guideline antiretroviral therapy (ART) eligible (prior ART experience or CD4 ≤ 350) with ≥1 HIV clinic visit between 2013 and 2017 in SEARCH communities randomized to intervention (N = 16) or control (N = 16). We assessed the effect of streamlined care in intervention community clinics (patient-centered care, increased appointment spacing, improved clinic access, reminders, and tracking) on VS at 3 years. Analysis was stratified by the baseline care status: ART-experienced with viremia, ART-naïve with CD4 ≤ 350, or ART-experienced with VS.

resultsAmong 6190 ART-eligible persons in care, year 3 VS was 90% in intervention and 87% in control arms (RR 1.03, 95% CI: 1.01 to 1.06). Among ART-experienced persons with baseline viremia, streamlined care was associated with higher VS (67% vs 47%, RR 1.41, 95% CI: 1.05 to 1.91). Among ART-naïve persons, VS was not significantly higher with streamlined care (83% vs 79%, RR 1.05, 95% CI: 0.95 to 1.16). Among ART-experienced persons with baseline VS, nearly all remained virally suppressed in both arms (97% vs 95%, RR 1.01, 95% CI: 1.00 to 1.03).

conclusionsStreamlined care was associated with higher viral suppression among ART-experienced patients with viremia in this randomized evaluation of ART-eligible patients who were in care after universal HIV testing.

Indexed as

Viral LoadAdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountDelivery of Health CareFemaleHIV InfectionsHumansKenyaMaleMiddle AgedTreatment OutcomeUgandaYoung AdultAnti-HIV Agents

Identifiers

PMID32991337
PMCPMC7654939
OpenAlexW3091199712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.